Journal list Promote Sponsor
verified SJR 1,074 · Q1 • database Scopus / SJR & Web of Science indexed
Pharmaceutical Statistics
United Kingdom · John Wiley and Sons Ltd
workspace_premium Q1 — Pharmacology lock_open Open Access

Pharmaceutical Statistics

Pharmaceutical Statistics is a journal indexed in SJR in Pharmacology and Statistics and Probability with an H index of 49. It has a price of 3000 €. It has an SJR impact factor of 1,074 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,074.

ISSN: 1539-1604
Publisher: John Wiley and Sons Ltd
Category: Pharmacology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,074 Q1
H-index 49
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.000 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,074

H-index

49

Docs (year)

96

Docs 3y

262

Total refs

3182

Cites 3y

503

Citable 3y

256

Cites/Doc 2y

1.49

Ref/Doc

33.15

Immediate OA

3000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Morbidity measures in the presence of recurrent composite endpoints

View more

Use of generalized estimating equations in a trial in influenza to explore treatment effects over time

View more

Tobit regression for modeling mean survival time using data subject to multiple sources of censoring

View more

The utility of experimental design short courses?

View more

The disagreeable behaviour of the kappa statistic

View more

The ABC of pharmaceutical trial design: some basic principles

View more

Top tip: ways of dealing with analytical constraints in pharmaceutical technology

View more

REGULATORY UPDATES: ICH E14 draft consensus guideline on clinical evaluation of QT/QTc interval prolongation

View more

Randomization in Clinical Trials: Theory and PracticeRosenberger WF, Lachin JM (2002) ISBN: 0471236268; 288 pages;

View more

Randomization as a basis for inference in noninferiority trials

View more

Power and sample size considerations in clinical trials with competing risk endpoints

View more

Negative binomial control limits for count data with extra-Poisson variation

View more
SHOW MORE ARTICLES

Sample size and the probability of a successful trial

View more

Modelling Survival Data in Medical Research (second edition) Collett D (2003)ISBN 1584883251; 408 pages; CRC Press;

View more

Modelling paired categorical outcomes in clinical trials

View more

Modelling covariance structure in ascending dose studies of isolated tissues and organs

View more

Modelling Binary Data (Second Edition) Collett D (2003)ISBN 1584883243; 387 pages; CRC Press;

View more

Modeling data with structural and temporal correlation using lower level and higher level multilevel models

View more

Mixture and mixture-process variable experiments for pharmaceutical applications

View more

Meta-analysis of QTc interval - pooling data from heterogeneous trials

View more

Lost opportunities for statistics

View more

Literature review, June 2003-September 2003

View more

Literature review September-December 2003

View more

Literature Review June-September 2004

View more

FAQs